Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: Final results of the randomized BEBYP trial

Gianluca Masi, L. Salvatore, L. Boni, F. Loupakis, C. Cremolini, L. Fornaro, M. Schirripa, S. Cupini, C. Barbara, V. Safina, C. Granetto, E. Fea, L. Antonuzzo, C. Boni, G. Allegrini, S. Chiara, D. Amoroso, A. Bonetti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: Final results of the randomized BEBYP trial'. Together they form a unique fingerprint.

Medicine & Life Sciences